Skip to content

Haemonetics HAE Net margin

Net margin at other companies

Abbott logo
AbbottABT
13.9%-18.0pp
TFX
TeleflexTFX
-47.4%-56.2pp
Boston Scientific logo
Boston ScientificBSX
17.3%+5.7pp
Medtronic logo
MedtronicMDT
13.2%-0.7pp
LivaNova logo
LivaNovaLIVN
-16.1%-18.0pp
ICU Medical logo
ICU MedicalICUI
-0.3%-0.2pp

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.37B-18.0%
Enterprise value$4.4B-12.5%
P/S2.5×-0.5×

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

Based on trailing twelve months.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's net margin?
Haemonetics (HAE) reported net margin of 13.3% in Q4 2025.
How has Haemonetics's net margin changed year-over-year?
Haemonetics's net margin increased by 40.5% year-over-year, from 9.5% to 13.3%.
What is the long-term trend for Haemonetics's net margin?
Over 4 years (2021 to 2025), Haemonetics's net margin has grown at a 7.8% compound annual growth rate (CAGR), from 9.1% to 12.3%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.